Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality.

Launched by FAIRTILITY · Apr 7, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new technology called CHLOE, which uses artificial intelligence (AI) to help assess the quality of eggs (oocytes) for women facing fertility challenges. The goal is to collect data that will help improve this technology, making it better at predicting which eggs are likely to lead to successful pregnancies. The researchers will also test how easy the CHLOE applications are to use, ensuring they are user-friendly for both patients and healthcare providers.

To be eligible for this trial, you need to be a woman aged 18 or older and have eggs or embryos that are being grown in a special incubator linked to the CHLOE system. However, if you are using your own eggs (autologous eggs), you won't be able to participate. If you join the trial, you'll be contributing to important research that could help many women in the future while also getting the chance to be part of a study that focuses on improving fertility treatments.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women at least 18 years of age.
• • Embryos or eggs cultured in a time-lapse incubator connected to CHLOE Embryo Viewer.
• Exclusion Criteria:
• • Women with autologous eggs